IMM Immupharma Plc

TIDMIMM

RNS Number : 1938D

Immupharma PLC

23 October 2015

 
 FOR IMMEDIATE RELEASE   23 OCTOBER 2015 
 

BOARD CHANGE

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that Ajay Agrawal has stepped down as Non-Executive Director with immediate effect.

Tim McCarthy, Non-Executive Chairman said: "We would like to thank Ajay for his contribution whilst at ImmuPharma.

"In the short period of time as Chairman, I have become more convinced of our lead programme Lupuzor. This has the potential to bring success for ImmuPharma, reward our long standing shareholders and ultimately to provide a significant treatment for lupus sufferers, globally. I am delighted to be part of the team driving this strategy forward."

-Ends-

For further information please contact:

 
                                               + 44 (0) 20 
 ImmuPharma plc                                  7152 4080 
 Tim McCarthy, Chairman 
 Lisa Baderoon, Head of Investor             + 44 (0) 7721 
  Relations                                         413496 
 
 Panmure, Gordon & Co., NOMAD &            +44 (0) 20 7886 
  Broker                                              2500 
 Fred Walsh, Duncan Monteith, Corporate 
  Finance 
  Charles Leigh-Pemberton, Corporate 
  Broking 
 
 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAPKBDQNBDBAKB

(END) Dow Jones Newswires

October 23, 2015 02:00 ET (06:00 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024